Indexing technology company MerQube completed in late July a Series B funding round which raised US$22m.

The funding round was led by Intel Capital with participation from new investor Allianz Life Ventures, and existing investors Citi, J.P. Morgan, Laurion Capital Management and UBS. SRP spoke to the firm’s CEO Vinit Srivastava and its chief commercial officer Roby Muntoni about the firm’s plans following the new injection of capital and the authorisation received by the UK Financial Conduct Authority (FCA) to offer benchmark administration under the Benchmarks Regulation (UK BMR).

Continue reading and get unlimited access for 7 days with a free trial of SRP.

Get a free trial

Already a subscriber? Login